About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.
(C) 2024 MINKABU THE INFONOID, Inc.

Astellas Pharma Inc.(4503) Summary

4503
TSE Prime
Astellas Pharma Inc.
1,512.5
JPY
-30.0
(-1.94%)
Dec 23, 10:04 am JST
9.64
USD
Dec 22, 7:33 pm EST
Result
PTS
outside of trading hours
1,512.5
Dec 23, 10:04 am JST
Summary Chart Historical News Financial Result
PER
54.1
PBR
1.77
Yield
4.89%
Margin Trading Ratio
30.74
Stock Price
Dec 23, 2024
Opening Dec 23, 9:00 am
1,530.0 JPY 9.77 USD
Previous Close Dec 20
1,542.5 JPY 9.83 USD
High Dec 23, 9:00 am
1,534.0 JPY 9.79 USD
Low Dec 23, 9:44 am
1,507.5 JPY 9.63 USD
Volume
1,597,600
Trading Value
2.43B JPY 0.01B USD
VWAP
1518.57 JPY 9.72 USD
Minimum Trading Value
151,250 JPY 964 USD
Market Cap
2.74T JPY 0.02T USD
Number of Trades
1,612
Liquidity & Number of Trades
As of Dec 23, 2024
Liquidity
High
1-Year Average
5,984
1-Year High Aug 6, 2024
25,178
Margin Trading
Date Short Interest Long Margin Positions Ratio
Dec 13, 2024 83,600 3,215,900 38.47
Dec 6, 2024 69,400 2,940,700 42.37
Nov 29, 2024 92,400 3,059,000 33.11
Nov 22, 2024 94,200 2,895,700 30.74
Nov 15, 2024 88,800 2,270,200 25.57
Company Profile
Astellas Pharma Inc. is the second-largest pharmaceutical company in Japan, specializing in innovative drugs. The company has particular strengths in urology and transplantation, and is focusing on anticancer drugs.
Sector
Pharmaceuticals